XML 82 R59.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders' Equity - Schedule of Restricted Stock and Contingent Restricted Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Weighted Average Grant-Date Fair Value    
Granted (in USD per share) $ 3.9 $ 3.58
Vesting-date intrinsic value of Restricted Stock $ 1,700 $ 1,600
Restricted Stock    
Number of Restricted Shares    
Unvested, beginning of period (in shares) 628,511 595,414
Vested (in shares) (326,431) (260,910)
Forfeited (in shares) (8,427)  
Unvested, end of period (in shares) 670,285 628,511
Weighted Average Grant-Date Fair Value    
Unvested, beginning of period (in USD per share) $ 6.31 $ 6.48
Vested (in USD per share) 6.6 5.85
Forfeited (in USD per share) 6.05  
Unvested, end of period (in USD per share) $ 5.58 $ 6.31
Unamortized compensation expense $ 2,196 $ 2,492
Weighted Average Remaining Amortization Period (Years) 1 year 7 months 6 days 1 year 9 months 18 days
Aggregate Intrinsic Value $ 3,150 $ 3,312
Restricted Stocks Time Vested    
Number of Restricted Shares    
Granted (in shares) 187,155 157,692
Unvested, end of period (in shares) 348,143  
Weighted Average Grant-Date Fair Value    
Granted (in USD per share) $ 5.7 $ 6.22
Unvested, end of period (in USD per share) $ 6.29  
Restricted Stock, Performance Based    
Number of Restricted Shares    
Granted (in shares) 189,477 136,315
Unvested, end of period (in shares) 322,142  
Weighted Average Grant-Date Fair Value    
Granted (in USD per share) $ 4.82 $ 4.8
Unvested, end of period (in USD per share) $ 4.81  
Contingent Restricted Stock Grants    
Number of Restricted Shares    
Unvested, beginning of period (in shares) 150,788 96,398
Forfeited (in shares) (3,394)  
Expired (in shares) (47,893) (47,849)
Unvested, end of period (in shares) 241,613 150,788
Weighted Average Grant-Date Fair Value    
Unvested, beginning of period (in USD per share) $ 2.86 $ 3.49
Forfeited (in USD per share) 2.91  
Expired (in USD per share) 4.77 2.19
Unvested, end of period (in USD per share) $ 2.37 $ 2.86
Unamortized compensation expense $ 340 $ 230
Weighted Average Remaining Amortization Period (Years) 1 year 9 months 18 days 1 year 7 months 6 days
Aggregate Intrinsic Value $ 1,136 $ 795
Performance Based Contingent Shares    
Number of Restricted Shares    
Granted (in shares) 142,112 102,239
Weighted Average Grant-Date Fair Value    
Granted (in USD per share) $ 2.67 $ 1.95